References

1. Gandhi MK, Khanna R (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4: 725-738 [CrossRef] [Google Scholar] [PubMed]
2. Hackert VH, van der Hoek W, Dukers-Muijrers N, de Bruin A, Al Dahouk S, et al. (2012) Q fever: single-point source outbreak with high attack rates and massive numbers of undetected infections across an entire region. Clin Infect Dis 55: 1591-1599 [CrossRef] [Google Scholar] [PubMed]
3. Ekman CC, Chiossi MF, Meireles LR, Andrade Júnior HF, Figueiredo WM, et al. (2012) Case-control study of an outbreak of acute toxoplasmosis in an industrial plant in the state São Paolo, Brazil. Rev Inst Med Trop Sao Paulo 54: 239-44 [CrossRef] [Google Scholar] [PubMed]
4. Lundstrom T, Sobel J (2001) Nosocomial candiduria: a review. Clin Infect Dis 32: 1602-1607 [CrossRef] [Google Scholar] [PubMed]
5. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, et al. (2005) Fruit bats as reservoirs of Ebola virus. Nature 438: 575-576 [CrossRef] [Google Scholar] [PubMed]
6. Davoust B, Bourry O, Gomez J, Lafay L, Casali F, et al. (2006) Surveys on seroprevalence of canine monocytic ehrlichiosis among dogs living in the Ivory Coast and Gabon and evaluation of a quick commercial test kit dot- ELISA. Ann N Y Acad Sci 1078: 464-469 [CrossRef] [Google Scholar] [PubMed]
7. Gentile G, Micozzi A (2016) Speculations on the clinical significance of asymptomatic viral infections. Clin Microbiol Infect 22: 585-588 [CrossRef] [Google Scholar] [PubMed]
8. Barton ES, White DW, Cathelyn JS, Brett-McLellan KA, Engle M, et al. (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447: 326-329 [CrossRef] [Google Scholar] [PubMed]
9. Ramsey KH, Cotter TW, Salyer RD, Miranpuri GS, Yanez MA, et al. (1999) Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection. Infect Immun. 67: 3019-3025 [Google Scholar] [PubMed]
10. Thaiss CA, Levy M, Suez J, Elinav E (2014) The interplay between the innate immune system and the microbiota. Curr Opin Immunol 26: 41-48 [CrossRef] [Google Scholar] [PubMed]
11. Cohen S, Janicki-Deverts D, Turner RB, Casselbrant ML, Li-Korotky HS, et al. (2013) Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults. JAMA 309: 699-705 [CrossRef] [Google Scholar] [PubMed]
12. Pfeiffer JK, Virgin HW (2016) Transkingdom control of viral infection and immunity in the mammalian intestine. Science [CrossRef] [Google Scholar]
13. Potasman I, Rzotkiewicz S, Pick N, Keysay A (2000) Outbreak of Q fever following a Safari trip. Clin Infect Dis 30: 214-215 [CrossRef] [Google Scholar] [PubMed]
14. Pacheco O, Beltrán M, Nelson CA, Valencia D, Tolosa N, et al. (2016) Zika virus disease in Colombia- a preliminary report. N Engl J Med [CrossRef] [Google Scholar] [PubMed]
15. Bischoff AR, Friedrich L, Cattan JM, Uberti FA (2016) Incidence of symptomatic congenital toxoplasmosis during ten years in a Brazilian hospital. Pediatr Infect Dis J 35: 1313-1316 [CrossRef] [Google Scholar] [PubMed]
16. Patrozou E, Mermel LA (2009) Does influenza transmission occur from asymptomatic infection or prior to symptom onset? Public Health Rep 124: 193-196 [CrossRef] [Google Scholar] [PubMed]
17. http://www.who.int/mediacentre/factsheets/fs094/en/ [View]
18. Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, et al. (2012) The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J 11: 29 [CrossRef] [Google Scholar] [PubMed]
19. Lindblade KA, Steinhardt L, Samuels A, Kachur SP, Slutsker L, et al. (2013) The silent threat: asymptomatic parasitemia and malaria transmission. Exper Rev Anti Infect Ther 11: 623-639 [CrossRef] [Google Scholar] [PubMed]
20. da Silva-Nunes M, Ferreira MU (2007) Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the symptomatic vs asymptomatic dichotomy. Memorias Do Instituto Oswaldo Cruz 102: 341– 347 [CrossRef] [Google Scholar] [PubMed]
21. Mabunda S, Aponte JJ, Tiago A, Alonso P (2009) A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Malar J 8: 74 [CrossRef] [Google Scholar] [PubMed]
22. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, et al. (2001) Increasing rates of malarial fever with deteriorating immune status in HIV- 1-infected Ugandan adults. AIDS 15: 899-906 [CrossRef] [Google Scholar] [PubMed]
23. Ndungu FM, Bull PC, Ross A, Lowe BS, Kabiru E, et al. (2002) Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2. Parasite Immunol 24: 77-82 [CrossRef] [Google Scholar] [PubMed]
24. Vinetz JM, Li J, McCutchan TF, Kaslow DC (1998) Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med 338:367-71 [CrossRef] [Google Scholar] [PubMed]
25. Montoya JG, Boothroyd JC, Kovacs JA (2010) Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, USA. Churchill Livingstone
26. Bowie WR, King AS, Werker DH, Isaac-Renton JL, Bell A, et al. (1997) outbreak of toxoplasmosis associated with municipal drinking water. The BC toxoplasma investigation team. Lancet 350: 173-177 [CrossRef] [Google Scholar] [PubMed]
27. Meireles LR, Ekman CCJ, de Andrade HF, Luna EJA (2015) Human toxoplasmosis outbreaks and the agent infecting form. Findings from a systematic review. Rev Inst Med Trop Sao Paolo 57: 369-376 [CrossRef] [Google Scholar] [PubMed]
28. Potasman I, Araujo FG, Remington JS (1986) Toxoplasma antigens recognized by naturally occurring human antibodies. J Clin Microbiol 24: 1050-1054 [Google Scholar] [PubMed]
29. Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 62: 2818-2824 [Google Scholar] [PubMed]
30. Vallochi AL, Goldberg AC, Falcai A, Ramasawmy R, Kalil J, et al. (2008) Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly. Clin Ophthalmol 2: 837-848 [CrossRef] [Google Scholar] [PubMed]
31. Wagner-Wiening C, Brockmann S, Kimmig P (2006) Serological diagnosis and follow-up of asymptomatic and acute Q fever infections. Int J Med Microbiol 40: 294-296 [CrossRef] [Google Scholar] [PubMed]
32. Broos PP, Hagenaars JC, Kampschreur LM, Wever PC, Bleeker-Rovers CP, et al. (2015) vascular complications and surgical interventions after world's largest Q fever outbreak. J Vasc Surg 62: 1273-1280 [CrossRef] [Google Scholar] [PubMed]
33. Maltezou HC, Raoult D (2002) Q fever in children. Lancet Infect Dis 2: 686-691 [Google Scholar] [PubMed]
34. Graham JG, MacDonald LJ, Hussain SK, Sharma UM, Kurten RC, et al. (2013) Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages. Cell Microbiol 15: 1012-1025 [CrossRef] [Google Scholar] [PubMed]
35. Vollmer-Conna U, Piraino BF, Cameron B, Davenport T, Hickie I, et al. (2008) Cytokine polymorphisms have a synergistic effect on severity of the acute sickness response to infection. Clin Infect Dis 47: 1418-1425 [CrossRef] [Google Scholar] [PubMed]
36. Crumpacker CS II, Zhang JL (2010) Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, USA. Churchill Livingstone
37. Green MS, Cohen D, Slepon R, Robin G, Wiener M, et al. (1993) Ethnic and gender differences in the prevalence of anti-cytomegalovirus antibodies among young adults in Israel. Int J Epidemiol 22: 720-723 [CrossRef] [Google Scholar] [PubMed]
38. Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, et al. (2013) A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 33: 751-758 [CrossRef] [Google Scholar] [PubMed]
39. Cannon MJ, Davis KF (2005) Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public health 5: 70 [CrossRef] [Google Scholar] [PubMed]
40. Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, et al. (2014) A Randomized Trial of Hyperimmune Globulin to Prevent Congenital Cytomegalovirus. N Engl J Med 370: 1316-1326 [CrossRef] [Google Scholar] [PubMed]
41. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF, et al. (1999) Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 180: 702-707 [CrossRef] [Google Scholar] [PubMed]
42. Polić B, Hengel H, Krmpotić A, Trgovcich J, Pavić I, et al. (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188: 1047-1054 [CrossRef] [Google Scholar] [PubMed]
43. Srinivasan A, Flynn P, Gu Z, Hartford C, Lovins R, et al. (2013) Detection of respiratory viruses in asymptomatic children undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer 60: 149-151 [CrossRef] [Google Scholar] [PubMed]
44. Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, et al. (2008) Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis 197: 382-389 [CrossRef] [Google Scholar] [PubMed]
45. http://www.who.int/mediacentre/factsheets/zika/en/ [View]
46. Martines RB, Bhatnagar J, de Oliveira Ramos AM, Davi HP, Iglezias SD, et al. (2016) Pathology of congenital Zika syndrome in Brazil: a case series. Lancet 388: 898-904 [CrossRef] [Google Scholar] [PubMed]
47. Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, et al. (2009) Zika Virus Outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 360: 2536-2543 [CrossRef] [Google Scholar]
48. Aubry M, Teissier A, Huart M, Merceron S, Vanhomwegen J, et al. (2017) Zika Virus seroprevalence, French Polynesia, 2014-2015. Emerg Infect Dis [CrossRef] [Google Scholar] [PubMed]
49. Moreira J, Peixoto TM, Siqueira AM, Lamas CC (2017) Sexually acquired Zika virus: a systematic review. Clin Microbiol Infect 23: 296-305 [CrossRef] [Google Scholar] [PubMed]
50. Galel SA, Williamson PC, Busch MP, Stanek D, Bakkour S, et al. (2017) First Zika-positive donations in the continental United States. Transfusion 57: 762-769 [CrossRef] [Google Scholar] [PubMed]
51. Sapparapu G, Fernandez E, Kose N, Bin Cao, Fox JM, et al. (2016) Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540: 443-447 [CrossRef] [Google Scholar] [PubMed]
52. Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, et al. (2016) Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection. Science 353: 823-826 [CrossRef] [Google Scholar] [PubMed]
53. Pardy RD, Rajah MM, Condotta SA, Taylor NG, Sagan SM, et al. (2017) Analysis of the T-cell response to Zika virus and identification of a novel CD8+ T-cell epitope in immunocompetent mice. PLoS Pathogen 13: e1006184 [CrossRef] [Google Scholar] [PubMed]